Cannabis Stocks Surge as US Considers Easing Marijuana Restrictions​

TIM BOHENUPDATED DEC. 14, 2025, 8:47 AM ET
Reviewed by Ben Sturgilland Fact-checked by Ellis Hobbs

SNDL Inc. stocks have been trading up by 25.97 percent following optimistic market response to strategic growth initiatives.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading SNDL

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Market Insights: Significant Developments

  • Cannabis stocks, including Canopy Growth, Tilray, and Aurora Cannabis, experienced notable gains as news reverberated regarding potential easing of marijuana restrictions by the US President.
  • Reports suggest that the US Government is evaluating the reclassification of marijuana, possibly treating it as a less dangerous substance, comparable to prescription medications.
  • SNDL shares rallied following these developments, reflecting market optimism surrounding potential regulatory shifts in the United States.

Consumer Staples industry expert:

Analyst sentiment – positive

SNDL is navigating substantial challenges, as reflected in its financial metrics. The company displays a problematic EBIT margin of -4.1% and an even more concerning pre-tax profit margin of -33.8%, underscoring persistent operational inefficiencies. Nevertheless, a relatively healthy gross margin of 47.5% suggests potential for profitability if costs are managed more effectively. A robust current ratio of 5 signals strong liquidity, which, along with a manageable debt-to-equity ratio of 0.14, offers a solid foundation for future initiatives. However, the negative ROE of -15.52% and ROA of -13.12% indicate poor returns on shareholder capital and overall assets, necessitating strategic adjustments to improve financial performance.

From a technical perspective, SNDL demonstrates volatile price action, characterized by recent strong upward movement, notably from a low of $1.64 to a peak of $2.28. This surge was backed by substantial volume, suggesting a break from prior consolidation phases, likely influenced by positive sector news. The dominant trend appears to be bullish in the short term, having established a higher high. For traders, a bullish strategy is advisable, with an entry point above $2.20 supported by strong momentum. Stop-loss orders should be judiciously placed below $1.70 to guard against volatility reversals, with attention to volume spikes for confirmation of sustained buying interest.

SNDL’s outlook is bolstered by the recent U.S. policy shift towards easing marijuana restrictions, sparking a rally across cannabis stocks. This sector-wide uptrend was reinforced by SNDL’s renewed share repurchase program, providing a positive signal of company confidence in undervaluation. SNDL’s performance shows strong recovery potential versus the broader Consumer Staples and Beverages – Alcoholic benchmarks, supported by favorable policy tailwinds and internal financial maneuvers. Key resistance levels must be monitored at $2.30, while support is credible around the $1.70 mark, offering a range for investors to strategize entries and exits. Overall, SNDL’s prospects are considerably uplifted by its strategic financial maneuvers and favorable regulatory developments.

Candlestick Chart

More Breaking News

Weekly Update Dec 08 – Dec 12, 2025: On Sunday, December 14, 2025 SNDL Inc. stock [NASDAQ: SNDL] is trending up by 25.97%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview: Analyzing SNDL’s Performance

Recent trading activity has painted a fluctuating picture of SNDL’s stock prices with a visible uptick. From an open price of $2.11 on December 11, 2025, the stock closed higher the following day at $2.2297. This signals investor interest likely fueled by political developments affecting the cannabis sector. Despite the optimism, challenges remain evident in SNDL’s financial metrics. The company shows a total revenue of $920.4M with a gross margin of 47.5%, yet the pretax profit margin stands at a shaky -33.8%.

Financial strength is mirrored by a robust current ratio of 5.0, indicating sound liquidity, while the EV/Sales ratio of 0.82 suggests reasonably valued stock relative to sales performance. The profitability metrics continue to struggle with negative return on assets of -13.12%, underscoring efficiency concerns. The earnings report portrays a net loss of $13.3M, coupled with a negative EPS of $-0.05 per share.

Investor sentiments remain cautiously optimistic, however, with an improving cash position bolstered by operational cash flows and reduced long-term debt obligations. The recent share buyback program, sanctioned to repurchase up to C$100M shares, further hints at attempts to strengthen stock value and shareholder confidence.

Conclusion

SNDL stands at a pivotal juncture, poised between emerging opportunities and existing operational challenges. Market optimism concerning US policy changes provides a tailwind, yet the journey remains precarious. As Tim Bohen, lead trainer with StocksToTrade, says, “A good trade setup checks all the boxes—volume, trend, catalyst. Don’t trade if you’re missing pieces of the puzzle.” For traders, short-term gains mirror hope, but SNDL’s enduring value will depend on efficacious strategic maneuvers amid evolving legislative landscapes. This narrative underscores the complexity and dynamism characterizing SNDL in an uncertain regulatory era.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.



The Game is Rigged

But Our AI-driven analysis Has Leveled the Playing Field

Sign up for access to institutional grade tools and insights – and join 10,000+ traders